Citation:Stewart GD, Van Neste L, Delvenne P, Delrée P, Delga A, McNeill SA, et al 2013

From Cancer Guidelines Wiki

Citation


Stewart GD, Van Neste L, Delvenne P, Delrée P, Delga A, McNeill SA, et al. Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study. J Urol 2013 Mar;189(3):1110-6 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/22999998.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
In men who have been referred with suspected prostate cancer, what are the prognostic factors that determine the need for further investigation following a prior negative biopsy?Katherine Sheridancompleted
In men who have been referred with suspected prostate cancer, what are the prognostic factors that determine the need for further investigation following a prior negative biopsy?Dr Albert Chetcuti BTech(Biotech) Hons, PhDcompleted

Compare quality appraisals for each clinical question

Cited by

  1. Follow-up to a negative prostate biopsy